Zacks Research Has Optimistic Outlook of CLB Q1 Earnings

Core Laboratories Inc. (NYSE:CLB) – Investment analysts at Zacks Research upped their Q1 2027 earnings per share (EPS) estimates for Core Laboratories in a report issued on Thursday, March 26th. Zacks Research analyst Team now anticipates that the oil and gas company will earn $0.20 per share for the quarter, up from their prior forecast of $0.19. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2027 earnings at $0.32 EPS.

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Core Laboratories has an average rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Stock Up 7.2%

CLB stock opened at $17.61 on Friday. The company has a market capitalization of $810.85 million, a P/E ratio of 26.28, a price-to-earnings-growth ratio of 15.37 and a beta of 1.10. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $20.36. The firm’s fifty day simple moving average is $17.81 and its 200-day simple moving average is $15.97. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.02 and a quick ratio of 1.57.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Core Laboratories had a net margin of 6.04% and a return on equity of 12.18%. The company had revenue of $138.26 million for the quarter, compared to the consensus estimate of $130.40 million. During the same quarter in the prior year, the company earned $0.22 EPS. Core Laboratories’s quarterly revenue was up 7.0% on a year-over-year basis. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS.

Institutional Investors Weigh In On Core Laboratories

Several hedge funds have recently bought and sold shares of the stock. Corient Private Wealth LLC purchased a new position in shares of Core Laboratories during the 4th quarter valued at approximately $219,000. T. Rowe Price Investment Management Inc. boosted its holdings in Core Laboratories by 14.8% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,042,208 shares of the oil and gas company’s stock worth $16,707,000 after buying an additional 134,050 shares in the last quarter. XTX Topco Ltd grew its position in Core Laboratories by 110.9% during the fourth quarter. XTX Topco Ltd now owns 54,273 shares of the oil and gas company’s stock valued at $870,000 after buying an additional 28,541 shares during the period. Old West Investment Management LLC acquired a new stake in Core Laboratories during the fourth quarter valued at $613,000. Finally, AQR Capital Management LLC increased its holdings in Core Laboratories by 32.6% in the fourth quarter. AQR Capital Management LLC now owns 49,818 shares of the oil and gas company’s stock valued at $799,000 after buying an additional 12,242 shares in the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date was Friday, February 13th. Core Laboratories’s dividend payout ratio (DPR) is currently 5.97%.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.